JPM vs RANI · P/E 14, rev $57.35B vs rev $3.4M
JPMorgan Chase & Co (JPM) versus Rani Therapeutics Holdings Inc (RANI) — a side-by-side from cached financials, not a winner call.
JPMorgan Chase & Co (JPM) is a banks - diversified company listed on US. It is led by Jamie Dimon.
Rani Therapeutics Holdings Inc (RANI) is a biotechnology company listed on US.
Latest reported JPM revenue for 2026-06-30 was $57.35B. Net income was $21.16B. Revenue was up 15.1% from 2026-03-31 to 2026-06-30. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
Latest reported RANI revenue for 2026-06-30 was $3.4M. Net income was -$14.4M. Revenue was up 100.0% from 2026-03-31 to 2026-06-30. RANI currently screens at market cap $41.5M.
JPM currently screens at market cap $805.69B and trailing P/E 14.2. RANI currently screens at market cap $41.5M.
Not investment advice. Open the JPM and RANI stock pages for the full models.
Not investment advice.